Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 42

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 42
---
 beneficial owner of Common Shares held in street name, in order to ensure your Common Shares are voted in the way you would prefer, you must provide voting instructions to your broker, bank or other agent by the deadline provided in the materials you receive from your broker, bank or other agent.

| Q: | What happens if I sell my Common Shares before completion of the Arrangement? |

| A: | If you transfer your Common Shares before completion of the Arrangement, you will have transferred your right                                                   
 to receive the Consideration in the Arrangement. In order to receive the Consideration, you must hold your Common Shares through completion of the Arrangement. |

The Record Date for Shareholders entitled to vote at the Special Meeting is earlier than the date on which the Arrangement will be consummated. So, if you transfer your Common Shares after the Record Date but before the Special Meeting, you will have transferred your right to receive the Consideration in the Arrangement but retained the right to vote at the Special Meeting.

| Q: | Are there risks I should consider in deciding whether to vote for the Arrangement Resolution? |

| Q: | What are the U.S. income tax consequences of the Arrangement? |

| A: | For a summary of certain U.S. federal income tax considerations of the Arrangement, see “Certain U.S.                                                                                                                                  
 Federal Income Tax Considerations of the Arrangement” in this Circular and Proxy Statement. Such summary is not intended to be legal or tax advice to any particular Shareholder. Shareholders should consult their tax and investment 
 advisors with respect to their particular circumstances.                                                                                                                                                                               |

21

| Q: | What are the Canadian income tax consequences of the Arrangement? |

| A: | For a summary of certain Canadian federal income tax considerations of the Arrangement, see “Certain                                                                                                                                      
 Canadian Federal Income Tax Considerations of the Arrangement” in this Circular and Proxy Statement. Such summary is not intended to be legal or tax advice to any particular Shareholder. Shareholders should consult their tax advisors 
 with respect to their particular circumstances.                                                                                                                                                                                           |

| Q: | Am I entitled to Dissent Rights? |

| A: | Only Registered Shareholders as of the Record Date are entitled to Dissent Rights. Shareholders should                                                                                                                                 
 carefully read the section entitled “Dissent Rights” if they wish to exercise Dissent Rights and seek their own legal advice as failure to strictly comply with the requirements set forth in Chapter XIV – Division I of the QBCA (as